Related Experiment Video

Updated: Jul 13, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Rotavirus gastroenteritis: why to back up the development of new vaccines?

Nathalie Parez1

  • 1Urgences Pédiatriques, Hôpital Trousseau, AP-HP, Université Pierre et Marie Curie, EA3500, 26 rue du Dr A Netter, 75571 Paris cedex 12, France. nathalie.parez@trs.aphp.fr

Comparative Immunology, Microbiology and Infectious Diseases
|August 19, 2007
PubMed

Insights

New rotavirus (RV) vaccines are needed because current options have limitations. Viral-like particle vaccines show promise for better RV disease prevention in children globally.

Area of Science:

  • Virology
  • Immunology
  • Pediatrics

Background:

  • Rotaviruses (RVs) are a primary cause of severe acute diarrhea in children globally.
  • Current preventive measures are insufficient, making vaccination crucial for controlling RV disease.
  • Existing rotavirus vaccines, while effective, present challenges in cost, efficacy, and safety, particularly regarding live attenuated viruses.

Purpose of the Study:

  • To highlight the limitations of current rotavirus vaccines.
  • To explore the need for novel, non-replicating vaccine strategies.
  • To discuss the potential of new vaccine approaches, including viral-like particles.

Main Methods:

  • Review of existing rotavirus vaccine technology and their limitations.
  • Exploration of alternative vaccine platforms and administration routes.
  • Consideration of epidemiological differences influencing vaccine development.

Main Results:

  • Current oral live attenuated rotavirus vaccines have implementation challenges in diverse settings.
  • Viral-like particle-based vaccines are emerging as a promising alternative.
  • New vaccine strategies are under investigation in preclinical and clinical studies.

Conclusions:

  • Development of new rotavirus vaccines is essential to overcome the drawbacks of current options.
  • Non-replicating vaccines, such as viral-like particles, offer a potential solution.
  • Tailoring rotavirus vaccine composition and delivery to specific epidemiological contexts is crucial for global health impact.

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...